New antibiotic duos battle Drug-Resistant kidney infections
NCT ID NCT05887908
Summary
This large, completed Phase 3 study tested whether two new combinations of antibiotics (cefepime/nacubactam and aztreonam/nacubactam) work as well as a standard antibiotic (imipenem/cilastatin) for treating serious urinary tract or kidney infections in adults. The main goal was to see if patients achieved both symptom relief and cleared the infection. Over 600 hospitalized adults participated in this blinded, randomized trial.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COMPLICATED URINARY TRACT INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Meiji Research Site
Pleven, Bulgaria
-
Meiji Research Site
Rousse, Bulgaria
-
Meiji Research Site
Silistra, Bulgaria
-
Meiji Research Site
Sofia, Bulgaria
-
Meiji Research Site
Beijing, China
-
Meiji Research Site
Changchun, China
-
Meiji Research Site
Chongqing, China
-
Meiji Research Site
Fuyang, China
-
Meiji Research Site
Ganzhou, China
-
Meiji Research Site
Huaian, China
-
Meiji Research Site
Huzhou, China
-
Meiji Research Site
Nanchang, China
-
Meiji Research Site
Nanning, China
-
Meiji Research Site
Quanzhou, China
-
Meiji Research Site
Shanghai, China
-
Meiji Research Site
Shantou, China
-
Meiji Research Site
Shijiazhuang, China
-
Meiji Research Site
Taian, China
-
Meiji Research Site
Tianjin, China
-
Meiji Research Site
Xuancheng, China
-
Meiji Research Site
Yunnan, China
-
Meiji Research Site
Zhejiang, China
-
Meiji Research Site
Zhengzhou, China
-
Meiji Research Site
Hradec Králové, Czechia
-
Meiji Research Site
Liberec, Czechia
-
Meiji Research Site
Prague, Czechia
-
Meiji Research Site
Ústí nad Labem, Czechia
-
Meiji Research Site
Meegomäe, Võrumaa, Estonia
-
Meiji Research Site
Kohtla-Järve, Estonia
-
Meiji Research Site
Tallinn, Estonia
-
Meiji Research Site
Tartu, Estonia
-
Meiji Research Site
Kutaisi, Georgia
-
Meiji Research Site
Rustavi, Georgia
-
Meiji Research Site
Tbilisi, Georgia
-
Meiji Research Site
Fukuyama, Japan
-
Meiji Research Site
Gifu, Japan
-
Meiji Research Site
Ibaraki-Town, Higashiibaraki-County, Japan
-
Meiji Research Site
Iwakuni, Japan
-
Meiji Research Site
Kanazawa, Japan
-
Meiji Research Site
Kawachi-Nagano, Japan
-
Meiji Research Site
Kofu, Japan
-
Meiji Research Site
Kumamoto, Japan
-
Meiji Research Site
Matsumoto, Japan
-
Meiji Research Site
Mizumaki-Town, Onga-County, Japan
-
Meiji Research Site
Nagasaki, Japan
-
Meiji Research Site
Nankoku, Japan
-
Meiji Research Site
Ōita, Japan
-
Meiji Research Site
Ōtake, Japan
-
Meiji Research Site
Sagamihara, Japan
-
Meiji Research Site
Sapporo, Japan
-
Meiji Research Site
Shinjuku-ku, Japan
-
Meiji Research Site
Toyota, Japan
-
Meiji Research Site
Ueda, Japan
-
Meiji Research Site
Yokohama, Japan
-
Meiji Research Site
Riga, Latvia
-
Meiji Research Site
Valmiera, Latvia
-
Meiji Research Site
Kaunas, Lithuania
-
Meiji Research Site
Vilnius, Lithuania
-
Meiji Research Site
Galanta, Slovakia
-
Meiji Research Site
Rimavská Sobota, Slovakia
-
Meiji Research Site
Svidník, Slovakia
Conditions
Explore the condition pages connected to this study.